Table 1 Clinical characteristics of the 294 study participants
Variable | Â | n (%) |
|---|---|---|
Age, years, mean ± SD |  | 51.1 ± 16.2 |
Men (%) | Â | 174 (59.2) |
BMI |  | 22.75 ± 4.55 |
Disease extent (pancolitis/left-sided/proctitis/others) | Â | 122/83/82/7 |
Smoking | Â | 22 (7.5) |
Drinking | Â | 120 (40.8) |
Medication | Â | Â |
 5-Aminosalicylates (%) |  | 269 (91.5) |
 Prednisolone (%) |  | 61 (20.8) |
 Azathioprine |  | 47 (16.0) |
 TNF-α monoclonal antibody (%) |  | 18 (6.1) |
Clinical remission (%) | Â | 172 (58.8) |
Mayo endoscopic subscore, mean ± SD |  | 1.17 ± 0.9 |
Partial mucosal healing (Mayo endoscopic subscore ≤ 1) (%) |  | 218 (63.2) |
Mucosal healing (Mayo endoscopic subscore  < 1) (%) |  | 90 (26.1) |
Eating behavior | Â | Â |
Eating speed | Â | Â |
 Slow |  | 40 (13.6) |
 Moderate |  | 98 (33.3) |
 Quick |  | 156 (53.1) |
Eating until full | Â | 183 (62.2) |
Skipping breakfast | Â | 40 (13.6) |
CRP (mg/dl), mean ± SD |  | 0.35 ± 0.79 |